Register for our free email digests:
Number To Know
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
There will be no Episode Payment Models nor the Cardiac Rehabilitation incentive payment model under a new reimbursement rule recently proposed by the US Centers of Medicare and Medicaid.
84.7% of patients treated with Endologix's endovascular graft for abdominal aortic aneurysms showed no aneurysm-related complications in interim results from the LEOPARD clinical study. This is a better statistic compared to other similar devices.
There are around 10,000 pharmacies in the US set up to provide lab tests and have CLIA-waived status. Pharmacy-based testing is one key area driving the growth in point-of-care diagnostics.
Abbott plans to enroll 75 patients in its feasibility study of a transcatheter clip-based tricuspid repair system. The results will support the CE marking of the device.
Five patients who received liquid-filled intragastric balloon systems from Apollo Endosurgery and ReShape Medical have died between now and 2016.
275 is the number of recalls initiated by medical device manufacturers in the second quarter of 2017. That's a 3% decrease from Q1.
There are 18 Austrian insurance funds that will reimburse Novocure's Optune device for treating adult patients with newly diagnosed glioblastoma across the country.
$9m is the amount Israeli neurovavscular technology company Rapid Medical raised in series B financing in July. The firm is under Medtech Insight's Start-Up Spotlight this month.
$10.4m is how much a jury has ordered Zoll Medical to pay Philips in a long-running patent infringement spat between the two rivals in the automated external defibrillator (AED) market. This award is only a fraction of what Philips had originally claimed for.
$30 is what Fresenius Medical Care, the global leader in dialysis management, has agreed to pay for each NxStage to acquire the home hemodialysis specialist.
Mainstay Medical has implanted its ReActiv8 restorative neurostimulation device for chronic lower back pain in 69 subjects in its US trial, marking the study's mid-point.
There were 25 M&A deal announced or completed in July.
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.